UEA CMP and MED scientists makes breakthrough in Prostate Cancer Research
New test which distinguishes prostate cancer 'tigers' from 'pussycats' developed by Prof Vincent Moulton (CMP) and Dr Bogdan Luca (CMP) collaborated with Prof Colin Cooper (MED) and Dr. Daniel Brewer (MED)
A new test has been developed to make the vital distinction between aggressive and less harmful forms of prostate cancer, helping to avoid sometimes-damaging and unnecessary treatment. Each year 46,000 men in the UK develop prostate cancer and many cancers progress after diagnosis to become life threatening. 11,000 men will die from the disease every year. Unlike many cancers, more than 50 per cent of prostate cancers cause no symptoms and are not life threatening. However, it has not been possible at the point of diagnosis to reliably distinguish these from clinically important cancers.
For more information, visit : New test distinguishes prostate cancer 'tigers' from 'pussycats'